Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
LTP
-0.21 (-1.70%)
Volume
45,276 Cr
Market Cap
₹67 Cr
52W Low - High
₹11.01 - ₹32.80
Sector
Textiles
LTP
-2.33 (-4.34%)
Volume
4,20,526 Cr
Market Cap
₹497 Cr
52W Low - High
₹30.20 - ₹78.23
Sector
Realty
LTP
-44.10 (-4.00%)
Volume
9,70,921 Cr
Market Cap
₹18,365 Cr
52W Low - High
₹736.60 - ₹1,143.80
Sector
Finance
LTP
-6.85 (-2.99%)
Volume
45,10,279 Cr
Market Cap
₹8,838 Cr
52W Low - High
₹87.50 - ₹243.99
Sector
Pharmaceuticals
LTP
0.23 (2.00%)
Volume
1,100 Cr
Market Cap
₹0 Cr
52W Low - High
₹4.72 - ₹11.73
Sector
Finance
With Zero Brokerage on Equity Delivery
The Piramal Group, led by Ajay Piramal since the early 1980s, has evolved into a global business conglomerate with a significant footprint in healthcare, life sciences, drug discovery, real estate, financial services, and glass packaging. Beginning with acquiring Gujarat Glass Limited in 1984 and Nicholas Laboratories in 1988, the group expanded through strategic acquisitions, including Roche’s Indian subsidiary in 1993 and Ceylon Glass Company in 1999.
Notably, in 2010, Piramal Healthcare sold its domestic formulations business to Abbott for $3.72 billion, marking one of the most expensive deals in the pharmaceutical industry. The group has also ventured into real estate with Piramal Realty and made significant contributions to healthcare and contract manufacturing, earning a spot among the top corporations in India and globally.
Piramal Group currently operates in sectors such as:
Ajay Piramal, Chairman and Executive Director
Ajay Piramal is the Chairman of the Piramal Group. He is considered to be a torchbearer for responsible entrepreneurship. He holds important positions on the Boards of various companies and prestigious institutions. He serves on the Harvard Business School’s Board of Dean’s Advisors, Non-Executive Director of Tata Sons Ltd, and co-chair of the UK-India CEO Forum.
Investing in Piramal Group stocks via Angel One is easy. Simply follow these steps:
If you don’t have a Demat account with Angel One, you can open one for free online within minutes.
The listed stocks of Piramal Group are Piramal Enterprises Ltd and Piramal Pharma Ltd.
As of January 20, 2024, the largest Piramal Group stock based on the market capitalisation is Piramal Enterprises Ltd. The market cap of the company is ₹20,021.33 crore.
The founder of Piramal Group is Ajay Piramal. He is also the Chairman and Executive Director of the Piramal Group.
Piramal Enterprises Ltd earned a net income of ₹48.19 crore in the quarter that ended September 30, 2023, making it the highest profit-making company in the Piramal Group.
Piramal Enterprises Ltd has the highest debt in the Piramal Group stock, where the total debt is ₹49,582.81 crore as of January 20, 2024.
Enjoy Zero Brokerage on
Equity Delivery